No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab.

about

No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab.

Item

http://www.wikidata.org/entity/Q50025315

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@en

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@nl

type

Item

label

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@en

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@nl

prefLabel

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@en

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@nl

P1476

No Relapse of Calcineurin Inhi ...... Discontinuation of Eculizumab.

@en

P2093

Andrzej Plis

http://www.w3.org/2001/XMLSchema#string

Christian Andreas Schmidt

http://www.w3.org/2001/XMLSchema#string

Christoph Busemann

http://www.w3.org/2001/XMLSchema#string

Laila Schneidewind

http://www.w3.org/2001/XMLSchema#string

Martin Weigel

http://www.w3.org/2001/XMLSchema#string

Sigrun Friesecke

http://www.w3.org/2001/XMLSchema#string

Stephanie-Susanne Stecher

http://www.w3.org/2001/XMLSchema#string

Sylvia Stracke

http://www.w3.org/2001/XMLSchema#string

Thomas Neumann

http://www.w3.org/2001/XMLSchema#string

William H Krüger

http://www.w3.org/2001/XMLSchema#string

P2860

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.

Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.

Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus.

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.

Can eculizumab be discontinued in aHUS?: Case report and review of the literature

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria.

Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.

P304

194-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000481724

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29136616

http://www.w3.org/2001/XMLSchema#string